We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Aviva Plc | LSE:AV. | London | Ordinary Share | GB00BPQY8M80 | ORD 32 17/19P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.60 | 0.77% | 472.00 | 472.10 | 472.30 | 474.50 | 468.60 | 470.00 | 3,223,825 | 16:35:01 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Insurance Carriers, Nec | 41.43B | 1.09B | 0.3962 | 11.92 | 12.93B |
Date | Subject | Author | Discuss |
---|---|---|---|
23/2/2021 07:26 | Shared risk above a certain level. Now it’s French owned they will probably have more luck with the court cases. | dr biotech | |
23/2/2021 07:18 | not denying that overall it is good news, just saying it is not as good as it might have been. | eurofox | |
23/2/2021 07:14 | @ Euro "This will have a negligible impact on Aviva's solvency position".....this comment is deliberately misleading then? I doubt it. We shall see in about 47 minutes I suppose. | muscletrade | |
23/2/2021 07:04 | confirmed, but aviva provides gt indemnity. not an ideal outcome. | eurofox | |
22/2/2021 22:29 | Well spotted BT. From figaro. They mention the golden ticket. The sale of insurer Aviva France takes a decisive step this week. According to our sources, Macif is expected to enter into exclusive negotiations to take over the subsidiary of the British insurer, which notably manages the life insurance contracts of Afer. In addition to the mutual insurer, four other candidates were in the running: insurers Allianz, Athora (backed by the Apollo fund), Generali and the investment company Eurazeo. Macif’s offer would cover all of Aviva France’s entities: non-life insurance and life insurance. Since the fall, Macif has been cited as a contender to take over Aviva France, which employs more than 4,500 people. In January, Adrien Couret, its leader, confirmed the interest of the group, which has just married Aésio Mutuelle to create Aéma. He also referred to "business complementarities" between Aviva France and Aéma, which aim to "multi-equip" its customers with insurance products. Aéma is now present in non-life insurance, health and provident insurance. 3.2 billion euros Macif’s candidacy has always been favored by the Aviva France trade unions, which see its project as a means of "preserving the future of employees" and therefore employment. It remains to be seen the position on the subject of Gérard Bekerman, the president of Afer, the leading savings association in France with 760,000 members. He claims a right of “consultation& Many rumors have circulated in recent months on the price that Macif would be willing to pay to get its hands on Aviva France. In January, Insurance Argus reported 3.2 billion euros. In any event, the cost will take into account the presence in the bride's basket of old ("known price") life insurance contracts that are extremely profitable for their holders and very expensive for the insurer. They are at the origin of disputes between Aviva France and its customers, involving millions of euros. | dr biotech | |
22/2/2021 22:07 | Figaro confirms on bid deadline of 22nd Feb Macif in pole position to acquire Aviva France. Bids for Poland by Friday 26th. Combined bids of 5.5 billion Euro suggested. | brilltrader | |
22/2/2021 16:16 | Dream on cyberian this old lady is 550 all day long for an offer it’s just trying to get near the median after COVID and Brexit | linton5 | |
22/2/2021 16:04 | If we are it’s sure to be a low one maybe the company should issue a rns saying they know no reason for this rise it’s such a rare event the powers that be have worked hard to keep the share price very low much like the AA before the offer was released. | wskill | |
22/2/2021 15:58 | Heck....are we about to receive an offer? | cyberian | |
22/2/2021 15:27 | Sweet today. 6% divi plus disposals in the billions. Nice train to be on rite now.. | devonbeachbum | |
22/2/2021 15:17 | On the long term chart this is still very low at this price smurfy | linton5 | |
22/2/2021 15:13 | Well l hit my 50% target but reckon this is going to breach 400p anytime soon. | smurfy2001 | |
22/2/2021 15:12 | Surely news this week on Poland and France | linton5 | |
22/2/2021 13:52 | Sigh.... I've had to take my bird feeding station down. No takers. A complete waste, sadly. The only interest I had all winter was from fat balls during the freeze. Pleased to see Aviva continuing to make progress. I might break even soon if this continues. | lord gnome | |
22/2/2021 13:44 | In lock down more folks putting out feeders the birds are probably spoilt for choice and probably put on weight and find it hard to fly from feeder to feeder. A question to our resident insurance experts are insurance rates generally hardening ? its a comment I have read several times in financial papers mainly I think in connection to reinsurance but is this accross the market? | mark1000 | |
22/2/2021 13:18 | Mark..a fair point...I have been steadily adding from recent lows and quite happy...there have been a few share price hiccups which can unsettle one but progress continues slowly but surely. Impossible to guess what our CEO has in her head but direction of travel looks OK. My bird feeders have been almost abandoned over the last 2 years in Central London...used to have at least 12 different types...not sure of the reason. | cyberian | |
22/2/2021 13:07 | Cyberian Hi in my world the price increases we have seen over the last three months in this share from 2.60 to 3.70 can hardly be described as a slow process. I am sitting in a conservatory watching birds on a feeder so I suppose its what you are used to as I like to say slow and steady gets you there every time. | mark1000 | |
22/2/2021 12:17 | Excuse me being lazy in avoiding trawling through all the various Announcements and BB posts What are the final closing dates for Formal Final Irrevocable Offers for the various businesses up for sale? | 1robbob | |
22/2/2021 11:10 | 21p To 390p ! | chinese investor | |
22/2/2021 10:32 | eurofox...very good news for both vaccines. I think the data was only related to figures from Scotland. but quite a relief that the Oxford/AstraZeneca achieved a higher success rate after all this nonsense from Germany and France. I had the Pfizer jab, and quite happy so far, but now rather pleased for many friends who have had the Astra/Oxford vaccine. Rather slow process here with AV. but just need to be patient...I think musculetrade post above hit the right note...of course delighted that BOFA have seen the light with a TP of 440p | cyberian | |
22/2/2021 10:15 | From the BBC, emerging data shows hospitalisations were reduced by 85% and 94% for the Pfizer and AstraZeneca jabs respectively. A really good showing for the AZ vaccine. | eurofox | |
22/2/2021 08:45 | BOFA RAISES AVIVA TO 'BUY' ('NEUTRAL') - TARGET 440 (388) PENCE | p0pper | |
22/2/2021 07:04 | Amanda Blanc quote from results earnings transcript 26th Nov 2019 "Once we have reached a sub 30 Solvency II leverage ratio, we expect to return excess capital to shareholders when the cover ratio is above 180%. This approach is consistent with maintaining our strong credit rating metrics. In terms of how we think about deployment of excess capital, we are absolutely committed to generating strong and sustainable shareholder value. We will look to reduce debt, return capital to shareholders and continue to invest in our core businesses where we see attractive opportunities to do so. We will carefully balance those priorities. And I will remind you that we already have a substantial amount of capital deployed within our core businesses to support growth". Having posted that I have some sympathy that we are getting a little ahead of ourselves in discussing methodology of how surplus cash is returned but this is just a personal view and not really of consequence. | muscletrade | |
21/2/2021 20:16 | Alot of posters getting carried away with talk of special divs, buybacks etc, ignoring the possibility that Aviva may spend surplus cash on an acquisition in UK/Canada/Ireland. IMO AB to date is not a fan of giving money to shareholders. | wm2020 | |
21/2/2021 20:12 | Thanks latics2 will give it a go . | wskill |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions